查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1444420

藥用塑膠瓶 - 市場佔有率分析、產業趨勢與統計、成長預測（2024 - 2029）

Pharmaceutical Plastic Bottles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 154 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年藥用塑膠瓶市場規模估計為92.2億美元，預計到2029年將達到112.6億美元，在預測期內（2024-2029年）CAGR為4.07%。

藥用塑膠瓶 - 市場

用於藥品儲存和運輸的藥品包裝需求不斷成長，預計將在預測期內推動市場發展。

主要亮點

  • 製藥業對塑膠包裝的需求因其無與倫比的能力而顯著成長。導致其在製藥業中更加採用的其他特性包括防潮、高尺寸穩定性、高衝擊強度、抗應變、低吸水性、透明性、耐熱性和阻燃性以及延長有效期。
  • 由於提高回收率和最大限度地減少製藥業對環境的影響，人們越來越關注永續性，因此藥用塑膠瓶市場不斷成長。技術進步以及塑膠瓶在固體甚至液體口服藥物中的應用不斷增加，促進了藥用塑膠瓶的市場成長。然而，由於原油價格波動和各種法規導致的塑膠價格上漲將反映在塑膠價格的上漲上，這可能會影響該產品的消費並進一步阻礙所研究市場的成長。
  • 塑膠瓶在業界擴大用於無菌填充和包裝。市場供應商在各地區提供無菌瓶填充和包裝服務。例如，LSNE 提供無菌滴管瓶填充服務。本公司擁有自動化填充線，可灌裝標準多劑量三片瓶5毫升、10毫升瓶及無菌多劑量瓶。
  • 亞太地區擁有重要的PET樹脂和聚合物生產基地，這也有助於市場的成長，且不存在原料供應短缺的問題。中國是PET瓶最大的生產國和消費國之一。
  • 隨著對藥品和其他必需品的需求不斷增加，達到歷史最高水準，缺乏可用的包裝來包裝和運輸進一步導致供應鏈的嚴重中斷。然而，對 COVID-19 患者使用的某些藥物的需求增加。其中包括一些麻醉劑、抗生素、肌肉鬆弛劑和一些標籤外藥物。這導致了製藥公司塑膠瓶的供應。

藥用塑膠瓶市場趨勢

HDPE 細分市場成長率最高

  • HDPE用於製造各種類型的瓶子，其中未著色的瓶子是半透明的，具有優異的挺度和阻隔性能。該材料有色素品種，可包裝製藥業的光敏藥物。這些材料適合包裝保存期限較短的產品。根據美國化學理事會統計，2021年，美國樹脂產量為1,239億磅，其中熱塑性塑膠約佔總產量的86%。高密度聚乙烯（HDPE）是當年產量最多的樹脂，產量達220億磅。
  • HDPE 還具有優異的耐化學性，這使其成為包裝各種化學品和醫藥產品的寶貴材料。據證明，著色 HDPE 瓶比未著色 HDPE 材料具有更高的抗應力開裂性。 HDPE 的吹塑應用使其比 PP 和 LDPE 材料更耐用、用途更廣泛。與其他形式的聚乙烯材料相比，它還具有優異的耐大多數溶劑性和高拉伸強度。
  • HDPE 也主要用於商業領域的大型容器，因為它在普通聚合物中具有較高的強度重量比，並且比 PP 更不易碎。它在成型時保持了輕量特性，使其適合較大的容器，如塑膠罐。
  • 此外，市場上多個參與者開展了各種研究和開發活動。例如，2021年 4月，Advil 製造商 GSK Consumer Healthcare（GSK）宣布承諾將超過 8,000 萬個 Advil 瓶中的塑膠含量減少20%，這將導致環境中的塑膠減少近 500,000 磅。到2022年，Advil 預計將減少商店和網路上出售的幾乎所有瓶子中的塑膠含量，但該品牌的 Easy Open 瓶子除外。新的阻隔樹脂技術減少了模製和製作高密度聚乙烯（HDPE）瓶所需的樹脂用量，同時保持阻隔保護性能。

北美佔重要市場佔有率

  • 由於塑膠容器和瓶子的消費和工業應用不斷增加，美國塑膠瓶市場預計將以穩定的速度成長。據塑膠工業協會（PLASTICS）表示，美國塑膠瓶的市場需求持續擴大。
  • 據Pharmaceutical Commerce表示，在美國，藥品市場成長。到2023年，預計美國人將在藥品上花費 635 至 6550 億美元。因此，美國將成為醫藥支出最大的國家。
  • 此外，根據Pharmaceutical Commerce表示，在美國，藥品市場成長。到2023年，預計美國人將在藥品上花費 635 至 6550 億美元。因此，它幾乎肯定是醫藥支出最多的國家。
  • 塑膠樹脂及製品產業擁有 1,932 家工廠，擁有 93,000 名員工。塑膠產品幾乎用於所有現代產品，在加拿大大多數經濟領域都有需求，其中包裝、建築和汽車三大類佔塑膠最終用途的 69%。

藥用塑膠瓶產業概況

藥用塑膠瓶市場因 Amcor Limited、Berry Plastics Group, Inc.、Aptar Pharma、Gerresheimer AG、Graham Packaging Company、Alpha Packaging 和 Alpack Plastic Packaging等眾多參與者的存在而變得分散。參與者採取了各種有機和無機策略，如併購、合作、新產品發布和合作來主導市場。

  • 2021年 12月 - Comar 宣布收購注塑和吹塑產品製造商 Omega Packaging。 Omega Packaging 的兒童安全（CR）瓶蓋系列和精密模具製造能力推進了 Comar 的策略，即透過端到端客製化製造能力和擴展的產品組合為醫療保健客戶提供服務。
  • 2021年 9月 - Clearlake Capital Group 投資組合公司 Pretium Packaging 同意從 Irving Place Capital 手中收購總部位於美國的 Alpha Packaging，收購金額未公開。 Alpha Packaging 和 Pretium Packaging 將使合併後的實體能夠為兩家公司的現有客戶群和新客戶提供廣泛的先進包裝解決方案。

附加優惠：

  • Excel 格式的市場估算（ME）表
  • 3 個月的分析師支持

目錄

第1章 簡介

  • 研究假設和市場定義
  • 研究範圍

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 市場概況
  • 產業吸引力－波特五力分析
    • 新進入者的威脅
    • 買方的議價能力
    • 供應商的議價能力
    • 替代產品的威脅
    • 競爭激烈程度
  • 產業價值鏈分析
  • 評估 COVID-19 對市場的影響

第5章 市場動態

  • 市場促進因素
    • 消費者對輕量藥瓶的需求不斷成長
    • 增加醫療保健和製藥支出以促進市場成長
  • 市場限制
    • 原料成本增加
    • 對塑膠使用的環境擔憂

第6章 市場細分

  • 按原料分類
    • 聚對苯二甲酸乙二酯（PET）
    • 聚丙烯（PP）
    • 低密度聚乙烯（LDPE）
    • 高密度聚乙烯（HDPE）
  • 依類型
    • 固體容器
    • 滴管瓶
    • 鼻噴瓶
    • 液體瓶
    • 口腔護理
    • 其他類型
  • 按地理
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 歐洲其他地區
    • 亞太
      • 中國
      • 印度
      • 日本
      • 亞太其他地區
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 拉丁美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 中東和非洲其他地區

第7章 競爭格局

  • 公司簡介
    • Amcor Limited
    • Gerresheimer AG
    • Berry Group Inc.
    • Aptar Pharma
    • O.Berk Company LLC
    • Alpha Packaging
    • Pro-Pac Packaging Ltd
    • COMAR LLC
    • Gil Plastic Products Ltd
    • Drug Plastics Group
    • Frapak Packaging

第8章 投資分析

第9章 市場機會與未來趨勢

簡介目錄
Product Code: 57357

The Pharmaceutical Plastic Bottles Market size is estimated at USD 9.22 billion in 2024, and is expected to reach USD 11.26 billion by 2029, growing at a CAGR of 4.07% during the forecast period (2024-2029).

Pharmaceutical Plastic Bottles - Market

The growing demand for the packaging in pharmaceuticals for the storage and delivery of medicines is expected to drive the market during the forecast period.

Key Highlights

  • The demand for plastic packaging has witnessed significant growth in the pharmaceutical industry because of its unmatched ability. Additional features that led to increased adoption in pharma are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.
  • The market for pharmaceutical plastic bottles is growing due to growing sustainability concerns by increasing the recycling rate and minimizing the environmental impact in the pharmaceutical industry. Technological advancement and the rising application of plastic bottles in solid and even liquid oral medicines have added to market growth for pharmaceutical plastic bottles. However, the rise in the price of plastics due to fluctuating prices of crude oil and various regulations would reflect on the increase in the price of plastics, which may affect the consumption of the product and further hinder the growth of the market studied.
  • Plastic bottles are increasingly used for aseptic filling and packaging in the industry. Market vendors provide aseptic bottle filling and packaging services in various regions. For instance, LSNE offers aseptic dropper bottle filling services. The company has an automated filling line capable of filling standard multi-dose three-piece bottles in 5 ml and 10 ml bottles and sterile multi-dose bottles.
  • Asia-Pacific has a prominent base for the production of PET resin and polymers, which is also aiding the growth of the market with no issues of a supply shortage of raw material. China is one of the largest producing and consuming countries of PET bottles.
  • With the increasing demand for medicine and other essential goods at an all-time high, a lack of available packaging to package and ship them further caused a significant interruption in supply chains. However, the demand increased for some medicines used in patients with COVID-19. These included some anesthetics, antibiotics, muscle relaxants, and some off-label medicines. This led to the supply of plastic bottles in the pharmaceutical companies.

Pharmaceutical Plastic Bottles Market Trends

HDPE Segment to Report the Highest Growth Rate

  • HDPE is used to manufacture various types of bottles, and among those, un-pigmented bottles are translucent, with excellent stiffness and barrier properties. The material has a pigmented variety, which can package light-sensitive drugs in the pharmaceutical industry. These materials are suited for packaging products with a short shelf life. According to American Chemical Council, in 2021, the United States produced 123.9 billion pounds of resins, in which thermoplastics accounted for roughly 86% of total production. High-density polyethylene (HDPE) was the most produced resin that year, with an output of 22 billion pounds.
  • HDPE also has excellent chemical resistance, which presents it as a valuable material for packaging various chemicals and medicinal products. Pigmented HDPE bottles are witnessed to have improved stress crack resistance than un-pigmented HDPE material. The blow-molding application of HDPE makes it more durable and more versatile than PP and LDPE materials. It also has excellent resistance to most solvents and high tensile strength compared to other forms of polyethylene materials.
  • HDPE is also primarily used for larger containers in the commercial sector as it has a high strength-to-weight ratio in common polymers and is less brittle than PP. It maintains a lightweight nature in molding, making it suitable for larger containers, like plastic canisters.
  • Further, there have been various research and development activities by multiple players in the market. For instance, in April 2021, Advil maker GSK Consumer Healthcare (GSK) announced a commitment to reducing the plastic in more than 80 million Advil bottles by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil is expected to reduce plastic in nearly all bottles available in stores and online, except the brand's Easy Open bottles. The new barrier resin technology reduces the amount of resin required to mold and craft the high-density polyethylene (HDPE) bottles while maintaining barrier protection properties.

North America Accounts for a Significant Market Share

  • The US plastic bottles market is estimated to grow at a steady rate, owing to the constantly increasing consumption and industrial applications of plastic-made containers and bottles. According to the Plastics Industry Association (PLASTICS), the market demand for plastic bottles continues to expand in the United States.
  • According to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans would spend USD 635 to USD 655 billion on pharmaceuticals. As a result, the United States will be the country with the greatest pharmaceutical spending.
  • Moreover, according to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans will spend USD 635 to USD 655 billion on pharmaceuticals. As a result, it will almost certainly be the country with the most significant pharmaceutical spending.
  • The plastic resin and products sector employs 93,000 people across 1,932 establishments. With usage in almost every modern product, plastic products are in demand in Canada in most sectors of the economy, with three categories packaging, construction, and automotive accounting for 69% of plastic end use.

Pharmaceutical Plastic Bottles Industry Overview

The pharmaceutical plastic bottle market is fragmented with the presence of many players like Amcor Limited. Berry Plastics Group, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging, and Alpack Plastic Packaging. The players have adopted various organic and inorganic strategies such as mergers & acquisitions, partnerships, new product launches, and collaborations to dominate the market.

  • December 2021 - Comar announced that it acquired Omega Packaging, an injection, and blow-molded product manufacturer. Omega Packaging's line of child-resistant (CR) closures and precision mold-building capabilities advance Comar's strategy to serve healthcare customers with end-to-end custom manufacturing capabilities and an expanded product portfolio.
  • September 2021 - Clearlake Capital Group portfolio company Pretium Packaging agreed to acquire US-based Alpha Packaging from Irving Place Capital for an undisclosed sum. Alpha Packaging and Pretium Packaging will allow the combined entity to offer a wide range of advanced packaging solutions to both firms' existing customer bases and new customers.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyer
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Growing Need for Lightweight Pharma Bottles by Consumers
    • 5.1.2 Increasing Spending on Healthcare and Pharmaceutical to Augment the Market Growth
  • 5.2 Market Restraints
    • 5.2.1 Increasing Raw Material Costs
    • 5.2.2 Environmental Concerns over Usage of Plastics

6 MARKET SEGMENTATION

  • 6.1 By Raw Material
    • 6.1.1 Polyethylene Terephthalate (PET)
    • 6.1.2 Poly Propylene (PP)
    • 6.1.3 Low-density Poly Ethylene (LDPE)
    • 6.1.4 High-density Poly Ethylene (HDPE)
  • 6.2 By Type
    • 6.2.1 Solid Containers
    • 6.2.2 Dropper Bottles
    • 6.2.3 Nasal Spray Bottles
    • 6.2.4 Liquid Bottles
    • 6.2.5 Oral Care
    • 6.2.6 Other Types
  • 6.3 By Geography
    • 6.3.1 North America
      • 6.3.1.1 United States
      • 6.3.1.2 Canada
    • 6.3.2 Europe
      • 6.3.2.1 United Kingdom
      • 6.3.2.2 Germany
      • 6.3.2.3 France
      • 6.3.2.4 Rest of Europe
    • 6.3.3 Asia-Pacific
      • 6.3.3.1 China
      • 6.3.3.2 India
      • 6.3.3.3 Japan
      • 6.3.3.4 Rest of Asia-Pacific
    • 6.3.4 Latin America
      • 6.3.4.1 Brazil
      • 6.3.4.2 Argentina
      • 6.3.4.3 Mexico
      • 6.3.4.4 Rest of Latin America
    • 6.3.5 Middle East & Africa
      • 6.3.5.1 Saudi Arabia
      • 6.3.5.2 United Arab Emirates
      • 6.3.5.3 South Africa
      • 6.3.5.4 Rest of Middle East & Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 Amcor Limited
    • 7.1.2 Gerresheimer AG
    • 7.1.3 Berry Group Inc.
    • 7.1.4 Aptar Pharma
    • 7.1.5 O.Berk Company LLC
    • 7.1.6 Alpha Packaging
    • 7.1.7 Pro-Pac Packaging Ltd
    • 7.1.8 COMAR LLC
    • 7.1.9 Gil Plastic Products Ltd
    • 7.1.10 Drug Plastics Group
    • 7.1.11 Frapak Packaging

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS